$QCRH SEC Filings

Filed On	Filing
20 Oct 2026	8-K: Results of Operations and Financial Condition Record diluted earnings per share (“EPS”) of $2.21 with net income of $36.4 million and a 1.52% return on average assets (“ROAA”)
20 Oct 2026	8-K: Regulation FD Disclosure Special Note Concerning Forward-Looking Statements. This document contains, and future oral and written statements of the Company and its management may contain, forward-looking statements within the meaning of Section 27A of the Securit...
24 Aug 2026	8-K: Other Events
07 Aug 2026	10-Q
05 Aug 2026	Form 4: Winter Reba K, EVP, COO Received 1,208 shares by exercise or conversion ($75.5K) · Acquired 419 Performance Shares (Option Exercise/Conversion)
05 Aug 2026	Form 4: Winter Reba K, EVP, COO Granted 1,160 Performance Shares
22 Jul 2026	8-K: Results of Operations and Financial Condition
22 Jul 2026	8-K: Regulation FD Disclosure
29 Jun 2026	11-K
10 Jun 2026	Form 4: Reasner Amy L, Director Bought 60 shares ($5.42K)
10 Jun 2026	Form 4: Ekizian Laura L, President & CEO, QCBT Received 750 shares by exercise or conversion ($33.8K) · Sold 750 shares ($71.2K)
08 Jun 2026	Form 4: Klein James D., President, CRBT Sold 428 shares ($26K)
05 Jun 2026	Form 4: Klein James D., President, CRBT Granted 376 Performance Shares · Received 94 shares by exercise or conversion ($6.25K)
03 Jun 2026	Form 4: Lee Nicole A, EVP, Chief HR Officer Received 234 shares by exercise or conversion ($9.08K)
26 May 2026	8-K: Submission of Matters to a Vote of Security Holders; Other Events
22 May 2026	S-3ASR
08 May 2026	10-Q
06 May 2026	SCHEDULE 13G/A
30 Apr 2026	Form 4: Klein James D., President, CRBT Sold 310 shares ($28.2K)
24 Apr 2026	Form 4: Reasner Amy L, Director Bought 100 shares ($8.84K)

Comments